CTI Industries Corp. news

   Watch this stock
Showing stories 1 - 10 of about 27   

Articles published

CTIB 4.45 -0.03 (-0.56%)
price chart
Big Movers - SanDisk Corp. (NASDAQ:SNDK), Oi SA (NYSE:OIBR), VOC Energy ...
On 23 June 2014 CTI Industries Corp. (NASDAQ:CTIB) a manufacturer and marketer of vacuum sealing systems, foil balloons, latex balloons, printed and laminated films, is pleased to announce that its United Kingdom subsidiary, CTI Balloons, Ltd.
Stock Highlights � Google Inc. (NASDAQ:GOOG), General Electric Company ...
CTI Industries Corp. (NASDAQ:CTIB) announced that it has received approval from the Israeli Ministry of Health (MOH) for PIXUVRI� (pixantrone).
Top 10 Nasdaq-traded stocks posting largest volume increases
CTI Industries Corp. : Approximately 20,900 shares changed hands, a 1,325.9 percent increase over its 65-day average volume.
Related articles »  
BUZZ-US Stocks on the Move-Haliburton, EMC Corp, CTI Biopharma
The Dow Jones industrial average was down 0.39 percent at 17,032.78, the S&P 500 was down 0.35 percent at 1,971.37 and the Nasdaq Composite was down 0.43 percent at 4,413.16.
BUZZ-US Stocks on the Move-Counterpath, Euro Tech, Intercloud  Reuters UK
Related articles »  
CaiTerra International Energy Corporation Announces Purchase of ...
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/28/14 -- CaiTerra International Energy Corporation (TSX VENTURE:CTI) ("Caiterra" or the "Company"), announces that, subject to regulatory approvals, the Company has entered into an agreement on July 25 ...
Deals of the day: Mylan finds its tax inversion partner
The round total is now $25.5 million, including a prior close from Domain Associates, CTI Life Sciences Fund and the Ontario Emerging Technologies Fund.
ROTH Capital's Debjit Chattopadhyay: Marriage of Diagnostics to New ...
An added advantage of the covalent linkages relates to simpler manufacturing with a predictable chemical outcome. In head-to-head animal ... The MacroGenics and CTI business models are unique, and each company is doing fairly well in its own space.
Related articles »  
CTI BioPharma Completes Recruitment in PERSIST-1 Pivotal Phase 3 Trial of ...
(CTI or the Company) (nasdaq and mta:CTIC) announced today that it has completed recruitment in the PERSIST-1 pivotal Phase 3 clinical trial of pacritinib, a novel oral JAK2/FLT3 inhibitor that is being evaluated for the treatment of myelofibrosis ...
Bullish Movers at Nasdaq: Albany Molecular Research. (NASDAQ:AMRI), Tower ...  Gaining Green
Related articles »  
Environmental activism moves from the streets to the boardroom
A landmark report released by ExxonMobil Corp. in March 2014 indicated that activist shareholders had struck a nerve in the debate over carbon asset liabilities.
Related articles »  
CTI adds seven, promotes three
... to joining CTI, McCafferty spent over 20 years in the pharmaceutical and biotechnology industries, working for companies such as A.H.